S188: TECLISTAMAB IN COMBINATION WITH DARATUMUMAB, A NOVEL, IMMUNOTHERAPY-BASED APPROACH FOR THE TREATMENT OF RELAPSED/REFRACTORY MULTIPLE MYELOMA: UPDATED PHASE 1B RESULTS. (23rd June 2022) - Rodriguez Otero, P.; D'Souza, A.; Reece, D.; van de Donk, N. W.; Chari, A.; Krishnan, A.; Martin, T.; Mateos, M. V.; Morillo, D.; Hurd, D.; Rosinol, L.; Balari, A. S.; et al.